Aside from the short term stimulus in the headlines, there is really no upside in product pipeline. The stock itself looks to be developing a HS pattern. Will probably be heading down in the short term. Consolidate in the mid term. Heading lower in the long term. This is assuming it has no major development in its products. Recipe for investment destruction.